DurgicalDurgical
EN
Open the app

Naloxone !

An opioid antagonist: it pushes opioids off their receptor and reverses an overdose within minutes. It does almost nothing when no opioid is present.

Updated 2026-11-01

The figure shows naloxone in the inactive mouse μ receptor; the structure also holds a nanobody and an allosteric modulator, which are hidden.

Target in 3D: μ-opioid receptor. PDB structure 9BJK (RCSB PDB, public domain). View the structure at RCSB PDB

Mechanism of action

Naloxone is a pure competitive antagonist at opioid receptors, with the highest affinity for the μ receptor. It takes the agonist's site, displaces it and holds the receptor in its inactive shape without activating the G protein. It thus reverses respiratory depression, sedation and miosis within minutes; in a dependent person it can trigger acute withdrawal.

  1. Competes with the opioid for the μ receptor and displaces it
  2. The receptor stays inactive: the Gi protein is not switched on
  3. The breathing center regains its drive within minutes
  4. It wears off sooner than many opioids: sedation can return

Pharmacokinetics

Absorption
Given intravenously, intramuscularly, subcutaneously or intranasally.
Metabolism
Liver, by glucuronidation (mainly naloxone-3-glucuronide).
Elimination
Kidney, as metabolites.
Half-life
About one and a half hours.
Onset and duration
Within about two minutes intravenously; a little longer intramuscularly or subcutaneously.

Indications

  • Opioid overdose (coma, respiratory depression and miosis), including fentanyl
  • Reversal of opioid-induced respiratory depression after anesthesia
  • Combined with sublingual buprenorphine to deter injection

Adverse effects

Common

  • Withdrawal symptoms in dependent people: agitation, sweating, vomiting, pain
  • Tachycardia and hypertension

Contraindications

  • Known hypersensitivity to naloxone

Key interactions

Opioid agonists (morphine, fentanyl)
Reverses their effect; in dependent people it precipitates withdrawal.
Buprenorphine
Its high affinity makes reversal harder and may need more naloxone.
Long-acting opioids (methadone)
They outlast naloxone: respiratory depression can return.

What is monitored

  • Respiratory rate and level of consciousness for several hours after waking
  • Signs of withdrawal

Test yourself

Think of the answer, then tap the question to see it.

What kind of ligand is naloxone at the μ receptor?

A pure competitive antagonist: it takes the agonist's site without activating the receptor and displaces the agonist.

Why does naloxone not work for a benzodiazepine overdose alone?

It acts only on opioid receptors; benzodiazepines act on the GABA-A receptor. Naloxone does almost nothing when no opioid is present.

Why is buprenorphine combined with naloxone in sublingual tablets?

Taken sublingually, naloxone is barely absorbed and does not interfere; if someone dissolves and injects the tablet, naloxone acts and precipitates withdrawal.

Add to my cards (3)

← Back to the class: Opioids and antagonists

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: Naloxone Injection: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2026); Opioid overdose (World Health Organization, 2025); NALOXONE HYDROCHLORIDE INJECTION, USP, AUTO-INJECTOR- naloxone hydrochloride injection, solution (DailyMed (U.S. National Library of Medicine), 2026); ATCDDD - ATC/DDD Index (WHO Collaborating Centre for Drug Statistics Methodology, 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.